IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for Covid-19

A phase-I clinical trial is expected to start in early 2021.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news